Download presentation
1
GDP Quality Management Risk Based Approach
Frank Peeters, Ph.D. GDP Responsible Person Raes Pharmaceutical Logistics Senior Consultant, Tobeas bvba Nimfenstraat 1, B-2800 Mechelen
2
Overview of GDP Regulations
3
Globalized Production: Potential Risk
4
Good Distribution Practices The New EU Regulation
EU GDP Act - Guidlines of 7 March 2013 on Good Distribution Practice of Medicinal Products for Human Use (2013/C 68/01) 5 Nov /C 343/01 Although the act specifically states products for Human use, the authorities and pharma clients extend it to veterinary products and IMP’s (investigational medicinal products)
5
The difference between GDP Compliance and Certification
Products are stored and distributed in a GDP-compliant manner. This ensures control over the distribution chain and consequently maintains the quality and integrity of medicinal products All storage & distribution activities require GDP compliance Certain activities require certification by the competent authorities, while others are only controlled by the marketing authorization holders (MAH) themselves Only storage activities currently require a GDP license Warehousing Storage: Months Storage in view of Transport Days -Weeks Cross Docking Storage: Hours Transport GDP license required Exempt of GDP license
6
EU GDP Act 2013/C 343/01 Effective 5 November 2013
1. Quality Management System 2. Personnel 3. Premises and Equipment 4. Documentation 5. Operations 6. Complaints, Returns, Suspected Falsified Medicinal Products and Medicinal Product Recalls 7. Outsources Activities 8. Self-Inspection 9. Transportation 10. Specific Provisions for Brokers New in the regulation: Risk Based Approach
7
Risk Based Approach: where does it apply for me?
8
“Risk” in the GDP Regulation:
23 times
9
“Risk” in the GDP Regulation:
23 times
10
“Risk” in the GDP Regulation:
23 times
11
“Risk” in the GDP Regulation:
23 times
12
Risk Management Avoid all risks that can have an impact on the product quality and on patient safety Risk Management: Don’t try to do everything Focus on the high risks The residual risk is “ALARP”: As Low As Reasonably Possible
13
How to Comply? Risk Management Guidelines
Medicinal Products: Eurdralex Annex 20 – Quality Risk Management Equals ICH Q9 – Quality Risk Management adopted 2005, in operation March 2008 Tripartite: EU, US & Japan FDA initiative, Pharmaceutical cGMPs for the 21st Century A Risk-Based Approach – Sep 2004 Medical Devices: ISO 14791:2000 2007
14
Link ICH Q8 (Pharmaceutical Development) with ICH Q10 (Pharmaceutical Quality Sytem)
15
Definition of Risk IEC « The likelihood of a specific hazardous event occuring within a specific period or in specific circumstances » IEEE « A measure of the probability and severity of undesired effects. Often taken as the simple product of probability and consequence » ISO Guide 51 « Combination of probability of harm and severity of harm »
16
Definition of Risk IEC « The likelihood of a specific hazardous event occuring within a specific period or in specific circumstances » IEEE « A measure of the probability and severity of undesired effects. Often taken as the simple product of probability and consequence » ISO Guide 51 « Combination of probability of harm and severity of harm»
22
Different Risk Classes
GDP Risk (Product) Business Risk Relating to the product (eg unavailability) Relating to the company (financial, reputation…) Safety risk (Safety Health Environment) Cosmetic Impact, Comfort
23
Risk Management Tools (see ICH Q9)
Basic risk management facilitation methods questionnaires check sheets flowcharts Risk ranking and filtering Failure Mode Effects Analysis (FMEA) Failure Mode, Effects and Criticality Analysis (FMECA) Hazard Analysis and Critical Control Points (HACCP) Fault Tree Analysis (FTA) Hazard Operability Analysis (HAZOP) Preliminary Hazard Analysis (PHA) Supporting statistical tools
24
Top-down Risk Assessment: Risk Ranking
Example: GDP criticality on equipment: Which Areas are GDP critical (eg Pharmaceutical vs Food) Which Systems are GDP critical Which Hardwore & Software Components are GDP critical Which User Requirements and Functions are GDP critical
25
Intermezzo: What are GDP Critical Systems?
which maintain the correct temperature conditions whereby there is a risk for contamination or mixup whereby an adequate turnover is assured (FEFO) that assure a safe and secure storage including during transportation that assure the delivery of the right products to the right addressee to perform planning tasks that may have impact a on timely delivery that are involved in tracing of faulty products that are involved in recall processes.
26
Top-down Risk Assessment: Risk Ranking
Example: GDP criticality on equipment: Which Areas are GDP critical (eg Pharmaceutical vs Food) Which Systems are GDP critical Which Hardwore & Software Components are GDP critical Which User Requirements and Functions are GDP critical
27
Risk Classification
28
Prioritization based on risk
Period Period Period Period 4
29
Risk Quantification
30
FMEA Tool (prior to actions)
31
FMEA tool (after actions)
32
Risc Reduction Strategy
Avoid Reduce Low Medium High Probability Accept Low Medium High Risc
33
Risk Acceptance After every Risk Analysis: Is your Risk Reduced?
Take a ‘Time Out” Ask yourself: DOES THIS FEEL RIGHT? Professionally Morally Ethically Is your Risk Reduced? Mitigation of the Severity? Reduction of the Probability? Increase of the Detectability? and then RISK ACCEPTANCE
34
The “Swiss Cheese” Approach: Building in safety measures
35
RISK REDUCTION STRATEGY
Conclusion: RISK BASED APPROACH = RISK KNOWLEDGE + RISK REDUCTION STRATEGY RISK BASED DECISION
36
Risk Based Decision Making
Hard Data Soft Data (Facts) Experience Hard Data + Soft Data + Experience = JUDGEMENT
40
Decision Making: Facts
Risk accompanies every decision You will never know all the facts – some assumptions must be made Most decisions are made at the emotional level (does it feel right?) Our brain is wired for speed, not for accuracy Beware of patterns – never confuse fact with assumption The decision making environment has a big impact Stress kills effective decision making Time is always your enemy
41
Understand the “problem”
Obtain Hard Data and information: The WHO The WHAT The WHY The HOW The WHEN
42
Understand the “problem”
Obtain Hard Data and information: The WHO The WHAT The WHY (ask 5 times WHY) The HOW The WHEN BUT AVOID PARALYSIS BY ANALYSIS
43
Remove Risk Increasing Factors
Structural Causes Inconsistent process, Unreliable equipment, Poor design/layout, Failure to standardize, Workload, Fatigue, Time pressure, Interruptions Prevention Workspace (Ergonomics) Lighting, Noise, Workflow not logical, Inadequate segregation of areas, Discomfort, Duration of Tasks, Inadequate maintenance of premises, Temperature too hot/cold, Visual distractions, Smells & pollutants Environmental Causes Cultural & Organization: Poor communication, Hierarchy, Bureaucratic, KPI’s encourage Under-reporting Accountability
44
Remove Risk Increasing Factors
Process Related Causes Unclear Procedures, Over dependency on memory, Relying on human vision, Too many checks and too often, Only see what you expect Prevention Information Related Causes Too many documents, too complex, inaccurate or not suited for the purpose Latest versions of instructions not available Inappropriate use of assumptions, only verbal communication Communication not given to all staff Staff who is using the documentation does not consult it Staff doesn’t understand the risk for the patient Individual (Physical, Mental) Tiredness, Illness, Hangovers & Drug abuse
45
Typical Quality Risk Management Process
Initiate Quality Risk Management Assessment Output/result of the Quality Risk Management Process Risk Identification Risk Reduction Risk Evaluation Risk Analysis Risk Acceptance Review Events Unacceptable Risk Control Risk Communication Risk Management Tools Review Last loop from review to control is typically used troughout the lifecycle of a product. Interactive Round Table Quality Risk Management November 13, 2008
Similar presentations
© 2024 SlidePlayer.com Inc.
All rights reserved.